Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Mise à jour : Il y a 4 ans
Référence : NCT00534313

Femme et Homme

Extrait

The purpose of this study is to determine an optimal abatacept dosing regimen for the treatment of active arthritis due to psoriatic arthritis in patients who have had a prior inadequate response to disease-modifying antirheumatic drugs, including methotrexate and tumor necrosis factor alpha-blockade compounds.


Critère d'inclusion

  • Psoriatic Arthritis


Liens